Both medications share similar GLP-1 class side effects, primarily nausea and GI symptoms during dose escalation that typically resolve within weeks
As an antimetabolite, 5FU imposes substantial metabolic stress, forcing cells that survive treatment to rapidly adapt
13, 204 adults who did not take any GLP-1 based medication) with obesity and at least one diagnosed autoimmune condition
Side Effects: What Women Should Know Both options share similar side effects because they contain semaglutide
Saxenda, the second to be approved, only achieved middling weight-management results for a large share of those who took it, and physicians were reticent to prescribe weight-loss medications after the disastrous effects of drugs such as fen-phen were revealed in the late 90s
Similarly, our study found that use of SGLT2is was associated with a lower but insignificant risk of incident NAFLD/NASH events (i.e., aOR [95% CI]: 0.85 [0.631.15])